of migraine. more than 4 million of them have at least 15 migraine days each month. even though many drugs prevent and treat these headaches,.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..
'indian ip and liabilities law barrier to pharma r&d investment'